Immunopeptides
Cells display short peptides on their surface through human leukocyte antigen (major histocompatibility complex) molecules, and T cells use them to tell healthy cells from infected or cancerous ones. A growing share of these immunopeptides comes from non-canonical sources, including small open reading frames.
Approaches
- Immunopeptidomics by mass spectrometry: isolating peptides bound to human leukocyte antigen molecules and identifying them at scale.
- Integrated search strategies that combine proteogenomic databases with mass spectrometry to find non-canonical class I and class II peptides.
- Translational studies that evaluate newly found peptides as candidate targets for tumor immunotherapy.

Selected publications
Journal of the American Society for Mass Spectrometry, 2021, 32(9), 2346–2357
* corresponding author; # equal contribution. Lab head in bold.
All publications →